🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07708207
Active, not recruiting Observational

Development and Validation of an AI Foundation Model for Frozen-Section Pathology

NCT07708207 · tracked via the Priya Life Science China tracker
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Observational
Started
2026-04-27
Last updated
2026-07-16

Condition(s) studied

CancerIntraoperative PathologyArtificial Intelligence (AI)

Study summary

This multicenter observational study aims to develop and validate an artificial intelligence foundation model for frozen-section pathology.

The study includes a retrospective phase and a prospective validation phase. Retrospective frozen-section pathology data will be used for model development, internal validation, and external validation. A prospective multicenter cohort of patients undergoing intraoperative frozen-section examination will then be enrolled to evaluate the model in a real-world clinical setting.

The model will analyze digitized frozen-section whole-slide images and will be evaluated for prespecified frozen-section pathology diagnostic tasks across multiple organ systems. Its performance will be assessed using pathological reference standards. The primary outcome is the area under the receiver operating characteristic curve. Secondary outcomes include accuracy, sensitivity, specificity, positive predictive value, and negative predictive value.

This study is observational and will not require research-mandated changes to routine clinical care.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing surgery with intraoperative frozen-section pathological examination. * Availability of complete clinical information and intraoperative frozen-section pathology records. * Availability of digitized frozen-section whole-slide images suitable for artificial intelligence analysis. Exclusion Criteria: * Frozen-section whole-slide images with inadequate quality for evaluation, including substantial blur, ghosting, severe artifacts, or insufficient diagnostic tissue. * Missing or indeterminate key clinical, intraoperative pathology, or pathological reference data required for the prespecified study task. * Withdrawal of informed consent in the prospective validation cohort, where applicable.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong Guangzhou China

More Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07708207 on ClinicalTrials.gov ↗ ← All trials in China